JCDSA  Vol.2 No.4 , December 2012
Concomitant Occurrence of Segmental Neurofibromatosis and Lung Adenocarcinoma
Neurofibromatosis type 1 (NF1) caused by a loss-of functional mutation in NF1 encoding neurofibromin is an autosomal dominant disorder characterized by café-au-lait spots, neurofibromas, intertriginous freckles, and Lisch nodules. Segmental neurofibromatosis (SN) represents a postzygotic mutation and loss of heterozygosity in neurofibromin. SN occurring in the elder persons may be associated with internal malignant tumors. Here, we reported a case of 58-year-old woman with concomitant occurrence of SN and lung adenocarcinoma. The onset of SN in aged persons would be a sign of concomitant occurrence of internal malignant tumors.

Cite this paper
R. Morita, N. Oiso and A. Kawada, "Concomitant Occurrence of Segmental Neurofibromatosis and Lung Adenocarcinoma," Journal of Cosmetics, Dermatological Sciences and Applications, Vol. 2 No. 4, 2012, pp. 265-266. doi: 10.4236/jcdsa.2012.24050.

[1]   S. E. Kim, E. P. Heo, T. J. Yoon and T. H. Kim, “Segmentally Distributed Neurofibromatosis Associated with Adenocarcinoma of the Colon,” The Journal of Dermatology, Vol. 29, No. 6, 2002, pp. 350-353.

[2]   B. Yalcin, G. G. Toy, E. Tamer, P. Oztas, D. Ko?, B. Dikicier and N. Alli, “Increased Expression of Segmental Neurofibromatosis with Bronchoalveolar Lung Carcinoma,” Dermatology, Vol. 209, No. 4, 2004, p. 342. doi:10.1159/000080862

[3]   A. Kajimoto, N. Oiso, K. Fukai and M. Ishii, “Bilateral Segmental Neurofibromatosis with Gastric Carcinoma,” Clinical and Experimental Dermatology, Vol. 32, No. 1, 2007, pp. 43-44.

[4]   J. D. Dang and P. R. Cohen, “Segmental Neurofibromatosis of the Distal Arm in a Man Who Developed Hodgkin lymphoma,” International Journal of Dermatology, Vol. 48, No. 10, 2009, pp. 1105-1109. doi:10.1111/j.1365-4632.2009.04132.x

[5]   S. Laycock-van Spyk, N. Thomas, D. N. Cooper and M. Upadhyaya, “Neurofibromatosis Type 1-Associated Tumours: Their Somatic Mutational Spectrum and Pathogenesis,” Hum Genomics, No. 5, Vol. 6, 2011, pp. 623-690.

[6]   F. Bourdeaut, A. Hérault, D. Gentien, G. Pierron, S. Ballet, S. Reynaud, R. Paris, G. Schleiermacher, C. Baumann, P. Philippe-Chomette, M. Gauthier-Villars, M. Peuchmaur, F. Radvanyi and O. Delattre, “Mosaicism for Oncogenic G12D KRAS Mutation Associated with Epidermal Nevus, Polycystic Kidneys and Rhabdomyosarcoma,” Journal of Medical Genetics, Vol. 47, No. 12, 2010, pp. 859-862. doi:10.1136/jmg.2009.075374